112 related articles for article (PubMed ID: 12370460)
1. Exercise tolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucose.
Ørngreen MC; Olsen DB; Vissing J
Neurology; 2002 Oct; 59(7):1046-51. PubMed ID: 12370460
[TBL] [Abstract][Full Text] [Related]
2. Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency.
Ørngreen MC; Ejstrup R; Vissing J
Neurology; 2003 Aug; 61(4):559-61. PubMed ID: 12939440
[TBL] [Abstract][Full Text] [Related]
3. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease.
Vissing J; Haller RG
N Engl J Med; 2003 Dec; 349(26):2503-9. PubMed ID: 14695410
[TBL] [Abstract][Full Text] [Related]
4. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.
Ørngreen MC; Dunø M; Ejstrup R; Christensen E; Schwartz M; Sacchetti M; Vissing J
Ann Neurol; 2005 Jan; 57(1):60-6. PubMed ID: 15622536
[TBL] [Abstract][Full Text] [Related]
5. No effect of resveratrol on fatty acid oxidation or exercise capacity in patients with fatty acid oxidation disorders: A randomized clinical cross-over trial.
Storgaard JH; Løkken N; Madsen KL; Voermans NC; Laforêt P; Nadaj-Pakleza A; Tard C; van Hall G; Vissing J; Ørngreen MC
J Inherit Metab Dis; 2022 May; 45(3):517-528. PubMed ID: 35066899
[TBL] [Abstract][Full Text] [Related]
6. Opuntia ficus-indica ingestion stimulates peripheral disposal of oral glucose before and after exercise in healthy men.
Van Proeyen K; Ramaekers M; Pischel I; Hespel P
Int J Sport Nutr Exerc Metab; 2012 Aug; 22(4):284-91. PubMed ID: 22805855
[TBL] [Abstract][Full Text] [Related]
7. Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.
Lehmann D; Motlagh L; Robaa D; Zierz S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054946
[TBL] [Abstract][Full Text] [Related]
8. Activity of hepatic but not skeletal muscle carnitine palmitoyltransferase enzyme is depressed by intravenous glucose infusions in lactating dairy cows.
Al-Trad B; Wittek T; Gäbel G; Fürll M; Reisberg K; Aschenbach JR
J Anim Physiol Anim Nutr (Berl); 2010 Dec; 94(6):685-95. PubMed ID: 20546068
[TBL] [Abstract][Full Text] [Related]
9. Acute renal failure due to carnitine palmitoyltransferase II deficiency.
Uzel B; Altiparmak MR; Ataman R; Serdengeçti K
Neth J Med; 2003 Dec; 61(12):417-20. PubMed ID: 15025419
[TBL] [Abstract][Full Text] [Related]
10. Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies.
Demaugre F; Bonnefont JP; Colonna M; Cepanec C; Leroux JP; Saudubray JM
J Clin Invest; 1991 Mar; 87(3):859-64. PubMed ID: 1999498
[TBL] [Abstract][Full Text] [Related]
11. Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy.
Roe CR; Yang BZ; Brunengraber H; Roe DS; Wallace M; Garritson BK
Neurology; 2008 Jul; 71(4):260-4. PubMed ID: 18645163
[TBL] [Abstract][Full Text] [Related]
12. Effect of changes in fat availability on exercise capacity in McArdle disease.
Andersen ST; Jeppesen TD; Taivassalo T; Sveen ML; Heinicke K; Haller RG; Vissing J
Arch Neurol; 2009 Jun; 66(6):762-6. PubMed ID: 19506137
[TBL] [Abstract][Full Text] [Related]
13. Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency.
Vissing J; Quistorff B; Haller RG
Arch Neurol; 2005 Sep; 62(9):1440-3. PubMed ID: 16157752
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency.
Yasuno T; Osafune K; Sakurai H; Asaka I; Tanaka A; Yamaguchi S; Yamada K; Hitomi H; Arai S; Kurose Y; Higaki Y; Sudo M; Ando S; Nakashima H; Saito T; Kaneoka H
Biochem Biophys Res Commun; 2014 May; 448(2):175-81. PubMed ID: 24780397
[TBL] [Abstract][Full Text] [Related]
15. [Molecular analysis of a patient with carnitine palmitoyltransferase II deficiency].
Akanuma J; Wataya K; Matubara Y; Yamamoto T; Kira J; Narisawa K
Rinsho Shinkeigaku; 1997 Jun; 37(6):532-5. PubMed ID: 9366186
[TBL] [Abstract][Full Text] [Related]
16. Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo.
Head A; Maxwell S; Kendall MJ
Br J Sports Med; 1997 Jun; 31(2):120-5. PubMed ID: 9192124
[TBL] [Abstract][Full Text] [Related]
17. Normal protein content but abnormally inhibited enzyme activity in muscle carnitine palmitoyltransferase II deficiency.
Lehmann D; Zierz S
J Neurol Sci; 2014 Apr; 339(1-2):183-8. PubMed ID: 24602495
[TBL] [Abstract][Full Text] [Related]
18. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.
Bruce CR; Thrush AB; Mertz VA; Bezaire V; Chabowski A; Heigenhauser GJ; Dyck DJ
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E99-E107. PubMed ID: 16464906
[TBL] [Abstract][Full Text] [Related]
19. Glucose ingestion during exercise blunts exercise-induced gene expression of skeletal muscle fat oxidative genes.
Civitarese AE; Hesselink MK; Russell AP; Ravussin E; Schrauwen P
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1023-9. PubMed ID: 16030063
[TBL] [Abstract][Full Text] [Related]
20. Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency.
Lewis SF; Vora S; Haller RG
J Appl Physiol (1985); 1991 Jan; 70(1):391-8. PubMed ID: 1826293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
